These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15175333)

  • 1. Tyrosine 547 constitutes an essential part of the catalytic mechanism of dipeptidyl peptidase IV.
    Bjelke JR; Christensen J; Branner S; Wagtmann N; Olsen C; Kanstrup AB; Rasmussen HB
    J Biol Chem; 2004 Aug; 279(33):34691-7. PubMed ID: 15175333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One site mutation disrupts dimer formation in human DPP-IV proteins.
    Chien CH; Huang LH; Chou CY; Chen YS; Han YS; Chang GG; Liang PH; Chen X
    J Biol Chem; 2004 Dec; 279(50):52338-45. PubMed ID: 15448155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of DPP-IV catalytic residues in enzyme-saxagliptin complex formation.
    Metzler WJ; Yanchunas J; Weigelt C; Kish K; Klei HE; Xie D; Zhang Y; Corbett M; Tamura JK; He B; Hamann LG; Kirby MS; Marcinkeviciene J
    Protein Sci; 2008 Feb; 17(2):240-50. PubMed ID: 18227430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structures of DPP-IV (CD26) from rat kidney exhibit flexible accommodation of peptidase-selective inhibitors.
    Longenecker KL; Stewart KD; Madar DJ; Jakob CG; Fry EH; Wilk S; Lin CW; Ballaron SJ; Stashko MA; Lubben TH; Yong H; Pireh D; Pei Z; Basha F; Wiedeman PE; von Geldern TW; Trevillyan JM; Stoll VS
    Biochemistry; 2006 Jun; 45(24):7474-82. PubMed ID: 16768443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structures of a bacterial dipeptidyl peptidase IV reveal a novel substrate recognition mechanism distinct from that of mammalian orthologues.
    Roppongi S; Suzuki Y; Tateoka C; Fujimoto M; Morisawa S; Iizuka I; Nakamura A; Honma N; Shida Y; Ogasawara W; Tanaka N; Sakamoto Y; Nonaka T
    Sci Rep; 2018 Feb; 8(1):2714. PubMed ID: 29426867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of human dipeptidyl peptidase IV in complex with a decapeptide reveals details on substrate specificity and tetrahedral intermediate formation.
    Aertgeerts K; Ye S; Tennant MG; Kraus ML; Rogers J; Sang BC; Skene RJ; Webb DR; Prasad GS
    Protein Sci; 2004 Feb; 13(2):412-21. PubMed ID: 14718659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selectivity among dipeptidyl peptidases of the S9b family.
    Bjelke JR; Kanstrup AB; Rasmussen HB
    Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(4):3-7. PubMed ID: 17543192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prolyl oligopeptidase family.
    Polgár L
    Cell Mol Life Sci; 2002 Feb; 59(2):349-62. PubMed ID: 11915948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis of proline-specific exopeptidase activity as observed in human dipeptidyl peptidase-IV.
    Thoma R; Löffler B; Stihle M; Huber W; Ruf A; Hennig M
    Structure; 2003 Aug; 11(8):947-59. PubMed ID: 12906826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha.
    Aertgeerts K; Levin I; Shi L; Snell GP; Jennings A; Prasad GS; Zhang Y; Kraus ML; Salakian S; Sridhar V; Wijnands R; Tennant MG
    J Biol Chem; 2005 May; 280(20):19441-4. PubMed ID: 15809306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of serine 624, aspartic acid 702, and histidine 734 as the catalytic triad residues of mouse dipeptidyl-peptidase IV (CD26). A member of a novel family of nonclassical serine hydrolases.
    David F; Bernard AM; Pierres M; Marguet D
    J Biol Chem; 1993 Aug; 268(23):17247-52. PubMed ID: 8102366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D-QSAR studies of Dipeptidyl peptidase IV inhibitors using a docking based alignment.
    Pissurlenkar RR; Shaikh MS; Coutinho EC
    J Mol Model; 2007 Oct; 13(10):1047-71. PubMed ID: 17676345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase binding.
    Aertgeerts K; Ye S; Shi L; Prasad SG; Witmer D; Chi E; Sang BC; Wijnands RA; Webb DR; Swanson RV
    Protein Sci; 2004 Jan; 13(1):145-54. PubMed ID: 14691230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity.
    Edosada CY; Quan C; Wiesmann C; Tran T; Sutherlin D; Reynolds M; Elliott JM; Raab H; Fairbrother W; Wolf BB
    J Biol Chem; 2006 Mar; 281(11):7437-44. PubMed ID: 16410248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipeptidyl peptidases 8 and 9: specificity and molecular characterization compared with dipeptidyl peptidase IV.
    Bjelke JR; Christensen J; Nielsen PF; Branner S; Kanstrup AB; Wagtmann N; Rasmussen HB
    Biochem J; 2006 Jun; 396(2):391-9. PubMed ID: 16475979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current advances and therapeutic potential of agents targeting dipeptidyl peptidases-IV, -II, 8/9 and fibroblast activation protein.
    Chen SJ; Jiaang WT
    Curr Top Med Chem; 2011; 11(12):1447-63. PubMed ID: 21510839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure activity relationship modelling of milk protein-derived peptides with dipeptidyl peptidase IV (DPP-IV) inhibitory activity.
    Nongonierma AB; FitzGerald RJ
    Peptides; 2016 May; 79():1-7. PubMed ID: 26988873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a tertiary-structure model of the C-terminal domain of DPP IV.
    Brandt W
    Adv Exp Med Biol; 2000; 477():97-101. PubMed ID: 10849734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dimeric transmembrane domain of prolyl dipeptidase DPP-IV contributes to its quaternary structure and enzymatic activities.
    Chung KM; Cheng JH; Suen CS; Huang CH; Tsai CH; Huang LH; Chen YR; Wang AH; Jiaang WT; Hwang MJ; Chen X
    Protein Sci; 2010 Sep; 19(9):1627-38. PubMed ID: 20572019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anagliptin, a potent dipeptidyl peptidase IV inhibitor: its single-crystal structure and enzyme interactions.
    Watanabe YS; Yasuda Y; Kojima Y; Okada S; Motoyama T; Takahashi R; Oka M
    J Enzyme Inhib Med Chem; 2015 Dec; 30(6):981-8. PubMed ID: 26147347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.